These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 12623949
1. Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury. Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S. Hypertension; 2003 Mar; 41(3):493-8. PubMed ID: 12623949 [Abstract] [Full Text] [Related]
4. Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats. Iwazu Y, Muto S, Hirahara I, Fujisawa G, Takeda S, Kusano E. J Hypertens; 2011 Dec; 29(12):2440-53. PubMed ID: 22045122 [Abstract] [Full Text] [Related]
12. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Karam H, Heudes D, Hess P, Gonzales MF, Löffler BM, Clozel M, Clozel JP. Cardiovasc Res; 1996 Feb; 31(2):287-95. PubMed ID: 8730406 [Abstract] [Full Text] [Related]
13. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide. Chen L, Gan XT, Haist JV, Feng Q, Lu X, Chakrabarti S, Karmazyn M. J Pharmacol Exp Ther; 2001 Aug; 298(2):469-76. PubMed ID: 11454907 [Abstract] [Full Text] [Related]
14. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension. Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W. Eur J Pharmacol; 2002 Feb 02; 436(3):207-16. PubMed ID: 11858800 [Abstract] [Full Text] [Related]
15. Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats. Young M, Funder JW. Endocrinology; 2004 Jul 02; 145(7):3153-7. PubMed ID: 15059952 [Abstract] [Full Text] [Related]
16. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Engelhardt S, Hein L, Keller U, Klämbt K, Lohse MJ. Circ Res; 2002 Apr 19; 90(7):814-9. PubMed ID: 11964375 [Abstract] [Full Text] [Related]
17. Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration. Fujisawa G, Dilley R, Fullerton MJ, Funder JW. Endocrinology; 2001 Aug 19; 142(8):3625-31. PubMed ID: 11459811 [Abstract] [Full Text] [Related]
18. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. Young MJ, Moussa L, Dilley R, Funder JW. Endocrinology; 2003 Mar 19; 144(3):1121-5. PubMed ID: 12586788 [Abstract] [Full Text] [Related]
19. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Görlach A, Wulff P, Daut J, Dalton ND, Ross J, Flögel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F. J Mol Med (Berl); 2006 May 19; 84(5):396-404. PubMed ID: 16604333 [Abstract] [Full Text] [Related]
20. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake. Vallee SM, Grillo CA, Gonzalez S, Cosen-Binker L, de Kloet ER, McEwen BS, De Nicola AF. Neuroendocrinology; 1995 Feb 19; 61(2):117-24. PubMed ID: 7753331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]